{{chembox
| Verifiedfields = changed
| verifiedrevid = 462093127
| ImageFile = Lodenosine.png
| ImageSize = 200px
| IUPACName = [(2''S'',4''S'',5''R'')-5-(6-Aminopurin-9-yl)-4-fluorooxolan-2-yl]methanol
| OtherNames =

| Section1 = {{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3WB2LGT4R1
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 65151
| InChI = 1/C10H12FN5O2/c11-6-1-5(2-17)18-10(6)16-4-15-7-8(12)13-3-14-9(7)16/h3-6,10,17H,1-2H2,(H2,12,13,14)/t5-,6-,10+/m0/s1
| InChIKey = KBEMFSMODRNJHE-JFWOZONXBK
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 501916
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C10H12FN5O2/c11-6-1-5(2-17)18-10(6)16-4-15-7-8(12)13-3-14-9(7)16/h3-6,10,17H,1-2H2,(H2,12,13,14)/t5-,6-,10+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = KBEMFSMODRNJHE-JFWOZONXSA-N
| CASNo_Ref = {{cascite|changed|??}}
| CASNo = 110143-10-7
| PubChem = 72180
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04759
| SMILES = F[C@H]3C[C@H](O[C@H]3n2cnc1c(ncnc12)N)CO
}}

| Section2 = {{Chembox Properties
| Formula = C<sub>10</sub>H<sub>12</sub>FN<sub>5</sub>O<sub>2</sub>
| MolarMass = 253.23 g/mol
| Appearance =
| Density =
| MeltingPt =
| BoilingPt =
| Solubility =
  }}

| Section3 = {{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt =
  }}
}}

'''Lodenosine''' is a failed experimental agent for the treatment of [[HIV]]. Its development was discontinued on January 11, 2001.<ref>{{cite web|title=Drug Profile: Lodenosine|url=http://adisinsight.springer.com/drugs/800005453|website=AdisInsight|publisher=Adis International Ltd, part of Springer Science+Business Media|accessdate=4 December 2015}}</ref>

{{Antiretroviral drug}}

==References==
{{Reflist}}

[[Category:Abandoned drugs]]
[[Category:Nucleoside analog reverse transcriptase inhibitors]]
[[Category:Organofluorides]]
[[Category:Purines]]


{{antiinfective-drug-stub}}